These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9451398)

  • 1. Withdrawal of nifedipine capsules: jeopardising the treatment of acute severe hypertension in pregnancy?
    Langton PE
    Med J Aust; 1998 Jan; 168(1):43-4. PubMed ID: 9451398
    [No Abstract]   [Full Text] [Related]  

  • 2. Withdrawal of nifedipine capsules: jeopardising the treatment of acute severe hypertension in pregnancy?
    Millar JA
    Med J Aust; 1998 Jan; 168(1):43; author reply 44. PubMed ID: 9451397
    [No Abstract]   [Full Text] [Related]  

  • 3. Withdrawal of nifedipine capsules: jeopardising the treatment of acute severe hypertension in pregnancy?
    Hassall JJ
    Med J Aust; 1998 Jan; 168(1):43; author reply 44. PubMed ID: 9451396
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and safety of nifedipine tablets for the acute treatment of severe hypertension in pregnancy.
    Brown MA; Buddle ML; Farrell T; Davis GK
    Am J Obstet Gynecol; 2002 Oct; 187(4):1046-50. PubMed ID: 12389003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies?
    Grossman E; Messerli FH; Grodzicki T; Kowey P
    JAMA; 1996 Oct 23-30; 276(16):1328-31. PubMed ID: 8861992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sublingual nifedipine compared with intravenous hydrallazine in the acute treatment of severe hypertension in pregnancy: potential for use in rural practice.
    Jegasothy R; Paranthaman S
    J Obstet Gynaecol Res; 1996 Feb; 22(1):21-4. PubMed ID: 8624887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the method for nifedipine administration for a rapid onset of clinical effect: a clinical study in normal volunteers.
    Kubota R; Komiyama T; Shimada H
    Yakugaku Zasshi; 2001 May; 121(5):355-64. PubMed ID: 11360489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of sublingual verapamil in patients with severe essential hypertension: comparison with sublingual nifedipine.
    Al-Waili NS; Hasan NA
    Eur J Med Res; 1999 May; 4(5):193-8. PubMed ID: 10336409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sublingual nifedipine in human pregnancy.
    Gallery ED; Györy AZ
    Aust N Z J Med; 1997 Oct; 27(5):538-42. PubMed ID: 9404584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of buccoadhesive formulations and sublingual capsules of nifedipine.
    Save T; Shah MU; Ghamande AR; Venkitachalam P
    J Pharm Pharmacol; 1994 Mar; 46(3):192-5. PubMed ID: 8027926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biowaiver Monographs for Immediate-Release Solid Oral Dosage Forms: Nifedipine.
    Gajendran J; Krämer J; Shah VP; Langguth P; Polli J; Mehta M; Groot DW; Cristofoletti R; Abrahamsson B; Dressman JB
    J Pharm Sci; 2015 Oct; 104(10):3289-98. PubMed ID: 26149619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative evaluation of the hypotensive effects of finoptin and corinfar after their sublingual administration].
    Kolesova MA; Orlov VM
    Klin Med (Mosk); 1988 Feb; 66(2):38-41. PubMed ID: 3286995
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
    Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sublingual nifedipine. A new approach to the therapy of hypertensive crisis in pregnancy].
    Lo Cicero G; Binaghi P; Cellina G; Limonta A
    Minerva Ginecol; 1986; 38(7-8):631-5. PubMed ID: 3748444
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetic and pharmacodynamic comparisons of oral and sublingual nifedipine in hypertensive Mexican patients.
    Palma-Aguirre JA; Roa-Mendieta A; Hernández-Jiménez LM; Girard-Cuesy ME; León-Urrea F; Alfaro-Mejía A; Frati A; Barreiro-Perera O
    Proc West Pharmacol Soc; 1993; 36():137-41. PubMed ID: 8378367
    [No Abstract]   [Full Text] [Related]  

  • 16. Dangers, myths, controversy. Sublingual nifedipine for hypertensive crisis.
    Kaufman SE; Schneider EF
    JAAPA; 2000 Mar; 13(3):67-8, 71-4, 80. PubMed ID: 11503405
    [No Abstract]   [Full Text] [Related]  

  • 17. Nifedipine in acute hypertensive emergencies in pregnancy.
    Seabe SJ; Moodley J; Becker P
    S Afr Med J; 1989 Sep; 76(6):248-50. PubMed ID: 2781421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic and pharmacodynamic differences between nifedipine capsule and GITS formulations in hypertensive patients.
    Isordia I; Carrasco M; Chávez-Negrete A; Palma-Aguirre JA; Flores-Murrieta FJ; Castañeda-Hernández G
    Int J Clin Pharmacol Ther; 1997 Mar; 35(3):133. PubMed ID: 9089004
    [No Abstract]   [Full Text] [Related]  

  • 19. Formulation dependent pharmacokinetics--does the dosage form matter for nifedipine?
    Toal CB
    J Cardiovasc Pharmacol; 2004 Jul; 44(1):82-6. PubMed ID: 15175561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutically relevant blood pressure differences with two nifedipine (60 mg) osmotic delivery systems of differing design: three case reports.
    Pollak PT
    Int J Clin Pharmacol Ther; 2010 Jun; 48(6):400-4. PubMed ID: 20497748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.